首页 | 本学科首页   官方微博 | 高级检索  
     


Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial
Authors:Rigby W  Tony H-P  Oelke K  Combe B  Laster A  von Muhlen C A  Fisheleva E  Martin C  Travers H  Dummer W
Affiliation:Dartmouth Medical School, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 03756-0001, USA. william.rigby@dartmouth.edu
Abstract:
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号